• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 77% to 6,621,025 units (SEC Form 4)

    1/6/25 2:46:30 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    JAGID JEFFREY M

    (Last) (First) (Middle)
    270 SYLVAN AVENUE, SUITE 2230
    ONE UNIVERSITY PLAZA

    (Street)
    ENGLEWOOD CLIFFS NJ 07632

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ATLANTIC INTERNATIONAL CORP. [ ATLN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    01/02/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, $.00001 par value 01/02/2025 01/02/2025 P 2,885,856 A $0.0001 6,621,025 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units(1) $0.0001 01/02/2025 01/02/2025 A 2,885,856 01/02/2025 07/02/2030 Common Stock 2,885,856 $0 2,885,856 D
    Explanation of Responses:
    1. These restricted stock units ("RSUs") were awarded under Mr. Jagid's Executive Employment Agreement dated June 18, 2024 with the Issuer. The RSUs were issued under the Company's 2023 Equity Incentive Plan in an exempt transaction pursuant to Rule 16b-3 under the Securities Exchange Act of 1934.
    /s/ Jeffrey Jagid 01/06/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ATLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Atlantic International Corp. Postpones Annual General Meeting

      ENGLEWOOD CLIFFS, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that it has postponed its Annual General Meeting, originally scheduled for July 15, 2025, has been postponed until a date to be determined later this year. About Atlantic International Corp. Atlantic International Corp. (NASDAQ:ATLN) is a publicly traded global platform of outsourced services and workforce solutions. Through its subsidiaries, including Lyneer Staffing Solutions, Atlantic provides tailored staffing, recruiting, and strategic outsourcing solutions across a wide range

      7/18/25 5:30:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Atlantic International Corp. Added to Membership of Russell 3000® Index

      ENGLEWOOD CLIFFS, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that it has been added as a member of the broad-market Russell 3000® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes annual reconstitution. The annual reconstitution of the Russell U.S. indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, results in automatic inclusion in either the large-cap Russell 100

      6/17/25 9:01:17 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Lyneer Staffing Solutions Integrates Advanced AI Capabilities into Proprietary Ecosystem, Advancing Data-Driven Workforce Solutions

      ENGLEWOOD CLIFFS, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions ("Lyneer") has successfully integrated cutting-edge artificial intelligence capabilities into its proprietary Apollo Ecosystem. This strategic enhancement positions Lyneer at the forefront of the staffing industry's digital transformation while maintaining its commitment to human-centered service delivery. The AI-powered Apollo Ecosystem now leverages advanced machine learning algorithms and predictive analytics to deliver unp

      6/5/25 12:00:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    SEC Filings

    See more
    • SEC Form RW filed by Atlantic International Corp.

      RW - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/14/25 4:05:04 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 424B3 filed by Atlantic International Corp.

      424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/8/25 4:31:45 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form EFFECT filed by Atlantic International Corp.

      EFFECT - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/7/25 12:15:24 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:11:34 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:04:40 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:02:59 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Financials

    Live finance-specific insights

    See more
    • Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

      Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

      3/28/25 7:30:00 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:11:34 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:04:40 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:02:59 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

      ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

      6/2/25 1:05:49 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials